NCT04767087Unknown2 期
Honey and Nigella Sativa in the Prophylaxis of COVID-19: A Randomized Controlled Trial
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- SARS-CoV-2 infection rate
研究概览
简要总结
Honey and Nigella sativa has established antiviral, antibacterial, anti-inflammatory, and immunomodulatory roles. So it is planned to test for its prophylaxis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Triple (Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Health care professionals Post-exposure COVID-19
排除标准
- •Multi-organ failure active COVID-19
研究组 & 干预措施
Honey and Nigella sativa Arm
Active Comparator
0.5 g/kg/day honey 40 mg/Kg/day Nigella sativa seeds
干预措施: Honey (Drug)
Honey and Nigella sativa Arm
Active Comparator
0.5 g/kg/day honey 40 mg/Kg/day Nigella sativa seeds
干预措施: Nigella sativa seed (Drug)
Placebo Arm
Placebo Comparator
empty capsule with sugar water
干预措施: Placebo (Other)
结局指标
主要结局
SARS-CoV-2 infection rate
时间窗: 14 days
RT-PCR SARS-CoV-2
次要结局
未报告次要终点
研究者
Sohaib Ashraf
Registrar Cardiology
Sheikh Zayed Federal Postgraduate Medical Institute
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Nigella Sativa in COVID-19COVID-19SARS-CoV-2NCT04401202King Abdulaziz University183
Unknown
3 期
Efficacy of Natural Honey Treatment in Patients With Novel CoronavirusCOVID-19NCT04323345Misr University for Science and Technology1,000
已完成
3 期
Honey & Nigella Sativa Trial Against COVID-19Sars-CoV2Coronavirus InfectionNCT04347382Sohaib Ashraf313
Unknown
2 期
New Mexico Honey Wound Treatment Research StudyCommunity-acquired Methicillin-resistant Staphylococcus Aureus InfectionNCT01748318R. Stephen Rankin, M.D.60
已完成
2 期
igella sativa and honey effect on kidney stonekidney stone.Calculus of kidneyIRCT20111105008013N6Ahvaz University of Medical Sciences40